M
S
SEARCH
MM
Tuesday, November 5
Collect News Data

Made In Chelsea's Louise Thompson diagnosed with Lupus

:Headline: Made In Chelsea's Louise Thompson diagnosed with Lupus:
Former Made In Chelsea star Louise Thompson reveals that she has been diagnosed with Lupus.
Sports Mole

Former Made In Chelsea star Louise Thompson has revealed that she has been diagnosed with the autoimmune disease Lupus.

The 32-year-old has been suffering from PTSD following the birth of her and fiancé Ryan Libbey's son Leo in November 2021.

Over the last year she has been open with fans about her health struggles and now doctors have confirmed that she is suffering from Lupus, an incurable disease which sees the body attack its own tissues and organs.

In a post on Instagram Stories, she said: I had a call yesterday with one of the rheumatology guys and they got more of my blood test results back and the diagnosis is that I've got drug-induced Lupus. So I'm suffering from that, which is fabulous."

She continued: "I feel like I'm constantly navigating so many different things and I could just cry, it all just feels so heavy.

"I was just on the bus going to one appointment this morning and when I stood up and started walking to the appointment, my knees were in such agony. I've never experienced anything like it in my life."

Thompson was a regular on the E4 reality series until 2020, when both she and Libbey left the show to start a family. body check tags ::

Follow us on X/Twitter and like us on Facebook for the latest entertainment news alerts.

Media Mole Low-Price Offer: Get Sky Entertainment, Sky Stream & Netflix for just £20 a month + £0 upfront fee for 24 months!
Prices may change during this period. Ends November 6, 2024

amp_article__502024 : Collect and Make Data not in DataBase  : 
last updated article - 2022-12-16 09:26:13:
html db last update - 2022-12-16 09:26:13 :

ex - 7200 : read : write cache and make html

Click here for more stories about Louise Thompson

Share this article now:






. . . . . . . . . . . . . . . .